Meditation: Clinical Trials

4 trials of Meditation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Meditation: new trials by email Literature Review of Meditation trials Research Report on Meditation

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Meditation-CBT for Opioid-treated Chronic Low Back Pain
Meditation-CBT Intervention + Usual Care, Usual Care Alone - Chronic Pain, Low Back Pain
Phase 1 / Phase 2CompletedUniversity of Wisconsin, Madison352013-01-012016-05-16
Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)
Progressive exercise, Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV, Modified paleolithic diet - Multiple Sclerosis
Phase 1CompletedUniversity of Iowa382010-10-012018-06-26
Hybrid Model of Vocal Inflammation and Tissue Mobilization
resonant voice, voice rest, Breathy voice - Acute Phonotrauma
Phase 1CompletedUniversity of Pittsburgh452010-09-012016-01-25
Basic Mechanisms of Meditation and Cardiovascular Disease in Older Blacks
Meditation - Cardiovascular Diseases
Phase 1CompletedNational Center for Complementary and Integrative Health (NCCIH)1999-09-012009-12-07

Conditions studied

Cardiovascular Diseases (1)  ·  Chronic Pain (1)  ·  Low Back Pain (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)

Sponsors

National Center for Complementary and Integrative Health (NCCIH) (1)  ·  University of Iowa (1)  ·  University of Pittsburgh (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (4)

Top investigators

Aleksandra Zgierska, MD PhD (1)  ·  Robert H. Schneider, MD (1)

Results publications

PMID 20025041, PMID 26968850

NIH funding

P50AT000082 (1), R01DC008290 (1)